Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial

Versteijne, Eva; Suker, Mustafa; Groothuis, Karin; M. Akkermans-Vogelaar, Janine; G. Besselink, Marc; A. Bonsing, Bert; Buijsen, Jeroen; R. Busch, Olivier; Creemers, Geert-Jan; M. van Dam, Ronald; A.L.M. Eskens, Ferry; Festen, Sebastiaan; Willem B. de Groot, Jan; Groot Koerkamp, Bas; H. J. T. de Hingh, Ignace; Y.V. Homs, Marjolein; E. van Hooft, Jeanin; D. Kerver, Emile; Luelmo, Saskia; J. Neelis, Karen; J. Nuyttens, Joost; Paardekooper, Gabriel; A. Patijn, Gijs; J.C. van der Sangen, Maurice; de Vos‐Geelen, Judith; W. Wilmink, Johanna; H. Zwinderman, Aeilko; J.A. Punt, Cornelis; H.J. van Eijck, Casper; van Tienhoven, Geertjan; the Dutch Pancreatic Cancer Group, for

doi:10.1200/jco.19.02274

Public

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial

Published in Journal of Clinical Oncology • Feb 27, 2020

Authors:

Eva Versteijne

Mustafa Suker

Karin Groothuis

Abstract

PURPOSE Preoperative chemoradiotherapy may improve the radical resection rate for resectable or borderline resectable pancreatic cancer, but the overall benefit is unproven. PATIENTS AND METHODS In this randomized phase III trial in 16 centers, patients with resectable or borderline resectable pancr...

Subject

Medicine

Gemcitabine

Chemoradiotherapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!